Abstract
Combination therapy for cancer patients is an important standard of care protocol because it can elicit synergistic therapeutic effects and reduce systemic toxicity by simultaneously modulating multiple cell-signaling pathways and overcoming multidrug resistance. Nanocarriers are expected to play a major role in delivering multiple drugs to tumor tissues by overcoming biological barriers. However, especially considering the different physical chemistry of chemotherapeutic drugs, it is highly desirable to develop a codelivery nanocarrier for controlled and targeted delivery of both hydrophobic and hydrophilic drugs. This review reports the recent developments in various combinational drug delivery systems and the simultaneous use of combinational drug delivery systems with functional agents.
| Original language | English |
|---|---|
| Pages (from-to) | 1499-1515 |
| Number of pages | 17 |
| Journal | Nanomedicine |
| Volume | 9 |
| Issue number | 10 |
| DOIs | |
| State | Published - 1 Jul 2014 |
Keywords
- combination therapy
- controlled drug release
- imaging
- nanocarrier
- stimuli-sensitive
- targeting
